Darrin Beaupre
CIK: 0001581198
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IDYA
IDEAYA Biosciences, Inc.
Officer
Discretionary Trading P&L
Holdings
About Beaupre Darrin
Beaupre Darrin (SEC CIK 0001581198) files insider reports with the SEC as Chief Medical Officer of IDEAYA Biosciences, Inc. (IDYA).
Signal8 holds 2 ownership filings by Beaupre Darrin, all Form 4s, filed between Feb 28, 2025 and Feb 2, 2026. Those filings report 2 transactions, from Feb 27, 2025 to Jan 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Beaupre Darrin's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Beaupre Darrin
Other insiders filing for IDEAYA Biosciences, Inc. (IDYA)
- Hata Yujiro S, President and CEO
- Ruiz Briseno Andres, Chief Accounting Officer
- YARNO WENDY L, Director
- Stein Jeffrey, Director
- ROSEN TERRY J, Director
- Morrison Scott W, Director